MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-11-2025
Evolent Health Retained Earnings 2011-2026 | EVH
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Evolent Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -606 M | -627 M | -589 M | -252 M | 50 M | 86 M | 147 M | 307 M | -25.8 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 307 M | -627 M | -168 M |
Quarterly Retained Earnings Evolent Health
| 2025-Q2 | 2024-Q2 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -865 M | - | -686 M | - | -595 M | - | -592 M | -627 M | -621 M | -608 M | -599 M | -589 M | -589 M | -589 M | -334 M | -252 M | -252 M | -252 M | -252 M | 50 M | 50 M | 50 M | 50 M | 86 M | 86 M | 86 M | 86 M | 147 M | 147 M | 147 M | 147 M | 307 M | 307 M | 307 M | 307 M | -25.8 M | -25.8 M | -25.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 307 M | -865 M | -172 M |
Retained Earnings of other stocks in the Health information services industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
6.75 B | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
8.13 M | - | 4.4 % | $ 133 M | USA |
 |
Change Healthcare
CHNG
|
-1.1 B | - | - | $ 9.03 B | USA |
 |
Accolade
ACCD
|
-372 M | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-517 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
580 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
301 M | - | - | $ 6.37 B | USA |
 |
Covetrus
CVET
|
-1.08 B | - | - | $ 2.94 B | USA |
 |
HealthStream
HSTM
|
109 M | $ 20.25 | 1.86 % | $ 615 M | USA |
 |
Progyny
PGNY
|
144 M | $ 21.14 | 0.76 % | $ 1.81 B | USA |
 |
Health Catalyst
HCAT
|
-1.19 B | $ 1.8 | -2.17 % | $ 108 M | USA |
 |
iCAD
ICAD
|
-277 M | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
-67.7 M | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
768 M | - | -10.39 % | $ 886 M | USA |
 |
HealthEquity
HQY
|
206 M | $ 73.06 | -0.2 % | $ 6.25 B | USA |
 |
American Well Corporation
AMWL
|
-2.06 B | $ 5.67 | 26.85 % | $ 91 M | USA |
 |
MTBC
MTBC
|
-66.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
So-Young International
SY
|
-926 M | $ 3.36 | -2.61 % | $ 267 M |  China |
 |
10x Genomics
TXG
|
-1.28 B | $ 19.49 | 11.31 % | $ 2.28 B | USA |
 |
GoodRx Holdings
GDRX
|
-1.44 B | $ 2.17 | -0.23 % | $ 837 M | USA |
 |
Omnicell
OMCL
|
383 M | $ 36.58 | 1.11 % | $ 1.68 B | USA |
 |
OptimizeRx Corporation
OPRX
|
-64.3 M | $ 8.82 | 7.43 % | $ 151 M | USA |
 |
1Life Healthcare
ONEM
|
-618 M | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
-485 M | - | - | $ 2.33 B | USA |
 |
Phreesia
PHR
|
-743 M | $ 12.11 | 2.15 % | $ 661 M | USA |
 |
Zhongchao
ZCMD
|
-7.96 M | $ 0.22 | -2.12 % | $ 1.15 M | China |
 |
R1 RCM
RCM
|
-64.3 M | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
-1.12 B | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
129 M | - | - | $ 1.6 B | USA |
 |
Schrödinger
SDGR
|
-526 M | $ 11.53 | 1.9 % | $ 838 M | USA |
 |
Signify Health
SGFY
|
-558 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-126 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
-16.2 B | $ 4.66 | 4.83 % | $ 795 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-408 M | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
2.74 B | $ 174.39 | 1.37 % | $ 28 B | USA |
 |
SCWorx Corp.
WORX
|
-31 M | $ 0.26 | 2.18 % | $ 379 K | USA |